Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Crystal Watson

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Health Security|June 5, 2020
Risk-Informed Decision Making: More Critical Today Than Ever BeforeCrystal Watson, Lucia Mullen
Neuropsychiatric Disease and Treatment|June 3, 2017
Characteristics, burden of illness, and physical functioning of patients with relapsing-remitting and secondary progressive multiple sclerosis: a cross-sectional US surveyHillary J Gross, Crystal Watson
Clinicoeconomics and Outcomes Research : CEOR|November 23, 2018
Multiple sclerosis patients who are stable on interferon therapy show better outcomes when staying on same therapy than patients who switch to another interferonChao Chen, Ning Wu, Crystal Watson
JAMA|August 20, 2024
The Resurgence of Mpox in AfricaCaitlin Rivers, Crystal Watson, Alexandra L Phelan
Health Security|June 28, 2017
Federal Funding for Health Security in FY2018Crystal Watson, Matthew Watson, Tara Kirk Sell
The New England Journal of Medicine|February 20, 2020
Emicizumab in Hemophilia ATyler W Buckner, Crystal Watson, Michael Recht
Journal of Drug Assessment|June 13, 2022
A review of the risks of long-term consequences associated with components of the CHOP chemotherapy regimenCrystal Watson, Hemanth Gadikota, Arie Barlev, et al.
CNS Drugs|June 27, 2015
Platform Therapy Compared with Natalizumab for Multiple Sclerosis: Relapse Rates and Time to Relapse Among Propensity Score-Matched US PatientsBarbara H Johnson, Machaon M Bonafede, Crystal Watson
Clinicoeconomics and Outcomes Research : CEOR|March 12, 2016
Short- and longer-term health-care resource utilization and costs associated with acute ischemic strokeBarbara H Johnson, Machaon M Bonafede, Crystal Watson
Clinicoeconomics and Outcomes Research : CEOR|January 1, 2014
Health care-resource utilization before and after natalizumab initiation in multiple sclerosis patients in the USMachaon M Bonafede, Barbara H Johnson, Crystal Watson
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Health Security|June 5, 2020
Risk-Informed Decision Making: More Critical Today Than Ever BeforeCrystal Watson, Lucia Mullen
Neuropsychiatric Disease and Treatment|June 3, 2017
Characteristics, burden of illness, and physical functioning of patients with relapsing-remitting and secondary progressive multiple sclerosis: a cross-sectional US surveyHillary J Gross, Crystal Watson
Clinicoeconomics and Outcomes Research : CEOR|November 23, 2018
Multiple sclerosis patients who are stable on interferon therapy show better outcomes when staying on same therapy than patients who switch to another interferonChao Chen, Ning Wu, Crystal Watson
JAMA|August 20, 2024
The Resurgence of Mpox in AfricaCaitlin Rivers, Crystal Watson, Alexandra L Phelan
Health Security|June 28, 2017
Federal Funding for Health Security in FY2018Crystal Watson, Matthew Watson, Tara Kirk Sell
The New England Journal of Medicine|February 20, 2020
Emicizumab in Hemophilia ATyler W Buckner, Crystal Watson, Michael Recht
Journal of Drug Assessment|June 13, 2022
A review of the risks of long-term consequences associated with components of the CHOP chemotherapy regimenCrystal Watson, Hemanth Gadikota, Arie Barlev, et al.
CNS Drugs|June 27, 2015
Platform Therapy Compared with Natalizumab for Multiple Sclerosis: Relapse Rates and Time to Relapse Among Propensity Score-Matched US PatientsBarbara H Johnson, Machaon M Bonafede, Crystal Watson
Clinicoeconomics and Outcomes Research : CEOR|March 12, 2016
Short- and longer-term health-care resource utilization and costs associated with acute ischemic strokeBarbara H Johnson, Machaon M Bonafede, Crystal Watson
Clinicoeconomics and Outcomes Research : CEOR|January 1, 2014
Health care-resource utilization before and after natalizumab initiation in multiple sclerosis patients in the USMachaon M Bonafede, Barbara H Johnson, Crystal Watson
Pageof 7